ranolazine has been researched along with Angina, Stable in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.00) | 29.6817 |
| 2010's | 43 (86.00) | 24.3611 |
| 2020's | 5 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez-Sendon, J; Tamargo, J | 1 |
| Dechend, R | 1 |
| Cesar, LAM; Dourado, LOC; Gowdak, LHW; Grobe, SF; Moreno, CPD | 1 |
| Ayyasamy, L; Bagepally, BS | 1 |
| Abacioglu, N; Chukwunyere, U; Sehirli, AO | 1 |
| Ahmed, B; Clegg, S; Mondragon, J; Sheldon, M | 1 |
| Balla, C; Ferrari, R; Pavasini, R | 1 |
| Coleman, CI; Kohn, CG; Nguyen, E; Weeda, ER | 1 |
| Bress, AP; Crook, J; Dodson, JA; Greene, T; King, JB; Knippenberg, K; LaFleur, J; Munger, MA; Nelson, RE; Radwanski, P; Reese, T; Sauer, BC; Weintraub, WS | 1 |
| Bleske, BE; Eyler, RF; Heung, M; Mueller, BA; Salama, NN; Scoville, BA; Segal, JH | 1 |
| Aichinger, J; Delle-Karth, G; Lang, I; Metzler, B; Wallner, E; Zweiker, R | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Katz, A; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| DeMaria, AN; Lew, WY | 1 |
| Rumsfeld, JS | 1 |
| Trujillo, TC | 1 |
| Bacchini, S; Barbieri, L; Bongo, AS; Cavallino, C; Degiovanni, A; Lazzero, M; Lupi, A; Nardi, F; Rametta, F; Rognoni, A; Veia, A | 1 |
| Grehan, S; Muhlestein, JB | 1 |
| Carbone, F; Mach, F; Montecucco, F | 1 |
| Geunes-Boyer, S; Hines, ME; Kloner, RA | 1 |
| Banon, D; Budlovsky, T; Eisenberg, MJ; Filion, KB; Franck, C | 1 |
| Coleman, CI; Kohn, CG; Limone, BL; Parker, MW | 2 |
| Biscaglia, S; Valgimigli, M | 1 |
| Aronow, WS; Khera, S; Kolte, D | 1 |
| Arnold, SV; Ben-Yehuda, O; Kosiborod, M; Li, Y; McGuire, DK; Spertus, JA; Yue, P | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| Castriota, F; Cremonesi, A; De Luca, G; Fattori, R; Lupi, A; Marino, PN; Mirabella, F; Parisi, R; Rognoni, A; Secco, GG | 1 |
| Dixit, D; Kimborowicz, K | 1 |
| Rognoni, A | 1 |
| Ghushchyan, V; Hartsfield, CL; Koch, BR; Nair, KV; Page, RL; Read, RA | 1 |
| Arnold, SV; Belardinelli, L; Chaitman, BR; Inzucchi, SE; Kosiborod, M; McGuire, DK; Spertus, JA; Tang, F; Yue, P | 1 |
| Blum, A | 1 |
| Coleman, CI; Freemantle, N; Kohn, CG | 1 |
| Afthonidis, D; Alexopoulos, D; Barbetseas, J; Kelembekoglou, P; Kochiadakis, G; Limberi, S; Spanos, A; Triantafyllidis, G | 1 |
| Cacciapuoti, F | 1 |
| Rayner-Hartley, E; Sedlak, T | 1 |
| Kourlaba, G; Maniadakis, N; Vardas, P; Vellopoulou, K | 1 |
| Ohman, EM | 1 |
| Rosano, GMC; Vitale, C; Volterrani, M | 1 |
| Vitaliivna Kuzminova, N; Yuriivna Osovska, N | 1 |
| Basilio Flores, JE; Loza Munárriz, C; Mejia Dolores, JW; Rey Rodriguez, DE; Salazar, CA; Veramendi Espinoza, LE | 1 |
| Melloni, C; Newby, LK; Truffa, AA | 1 |
| Franck, AJ; Frohnapple, DJ; Gillette, MA; Reeder, DN | 1 |
| Ben-Yehuda, O; Cheng, ML; Lee, S; Sendón, JL | 1 |
| De Silva, R; Purcell, H | 1 |
| Biasillo, G; Cardillo, MT; Della Bona, R; Gustapane, M | 1 |
| Demare, P; Hernández-Díaz, C; Mascher, D; Monsalvo, I; Paredes-Carbajal, MC; Regla, I | 1 |
| Di Monaco, A; Sestito, A | 1 |
| Stone, PH; Wimmer, NJ | 1 |
| Keating, GM | 1 |
22 review(s) available for ranolazine and Angina, Stable
| Article | Year |
|---|---|
Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
Topics: Acetanilides; Angina, Stable; Coronary Artery Disease; Humans; Piperazines; Quality of Life; Ranolazine | 2022 |
Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis.
Topics: Acetanilides; Angina, Stable; Cost-Benefit Analysis; Humans; Myocardial Ischemia; Ranolazine | 2023 |
Treatment of Angina: Where Are We?
Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chest Pain; Humans; Ivabradine; Nicorandil; Patient Selection; Practice Guidelines as Topic; Ranolazine; Treatment Outcome; Trimetazidine | 2018 |
Ranolazine: effects on ischemic heart.
Topics: Acetanilides; Angina, Stable; Animals; Arrhythmias, Cardiac; Clinical Trials as Topic; Diabetes Mellitus; Drug Interactions; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium Channel Blockers | 2013 |
Update on evidence for treatment with ranolazine in stable angina.
Topics: Acetanilides; Angina, Stable; Humans; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2013 |
Efficacy and safety of ranolazine in patients with chronic stable angina.
Topics: Acetanilides; Angina, Stable; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Geriatrics; Glycated Hemoglobin; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2013 |
The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Enzyme Inhibitors; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2014 |
Stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vasospasm; Echocardiography, Stress; Exercise Test; Humans; Ivabradine; Microvessels; Nicorandil; Nitrates; Percutaneous Coronary Intervention; Piperazines; Ranolazine; Smoking Cessation; Vasodilator Agents | 2014 |
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization.
Topics: Angina, Stable; Animals; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Trimetazidine | 2015 |
Pharmacologic management of chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents | 2015 |
Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Oxygen Consumption; Ranolazine | 2016 |
Ranolazine: A Contemporary Review.
Topics: Angina, Stable; Animals; Cardiovascular Agents; Chronic Disease; Drug Interactions; Drug Labeling; Humans; Off-Label Use; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2016 |
A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.
Topics: Angina, Stable; Cardiovascular Agents; Cost-Benefit Analysis; Humans; Ranolazine; Treatment Outcome | 2016 |
CLINICAL PRACTICE. Chronic Stable Angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Coronary Artery Disease; Humans; Male; Myocardial Revascularization; Nitrates; Practice Guidelines as Topic; Ranolazine | 2016 |
Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
Topics: Angina, Stable; Animals; Cardiovascular Agents; Humans; Ranolazine | 2016 |
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
Topics: Adult; Angina, Stable; Atrial Fibrillation; Bundle-Branch Block; Cardiovascular Agents; Female; Humans; Microvascular Angina; Middle Aged; Ranolazine; Treatment Outcome | 2016 |
Ranolazine for stable angina pectoris.
Topics: Angina, Stable; Cardiovascular Agents; Cause of Death; Humans; Incidence; Middle Aged; Myocardial Infarction; Quality of Life; Randomized Controlled Trials as Topic; Ranolazine | 2017 |
Extended-release ranolazine: critical evaluation of its use in stable angina.
Topics: Acetanilides; Angina, Stable; Animals; Cardiovascular Agents; Delayed-Action Preparations; Humans; Piperazines; Quality of Life; Ranolazine; Treatment Outcome | 2011 |
[Ranolazine in the treatment of chronic stable angina].
Topics: Acetanilides; Angina, Stable; Cardiovascular System; Humans; Piperazines; Ranolazine | 2012 |
The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina, Stable; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chronic Disease; Coronary Artery Bypass; Disease Management; Heart Function Tests; Humans; Membrane Transport Modulators; Myocardial Ischemia; Nitrates; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Ranolazine | 2012 |
Anti-anginal and anti-ischemic effects of late sodium current inhibition.
Topics: Acetanilides; Angina, Stable; Clinical Trials as Topic; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Treatment Outcome | 2013 |
Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; Treatment Outcome | 2013 |
8 trial(s) available for ranolazine and Angina, Stable
| Article | Year |
|---|---|
Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.
Topics: Administration, Oral; Adult; Angina, Stable; Area Under Curve; Biological Variation, Population; Cardiovascular Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Prospective Studies; Ranolazine; Renal Dialysis; Tablets; Young Adult | 2019 |
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Topics: Acetanilides; Aged; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents | 2013 |
Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Costs; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Piperazines; Quality-Adjusted Life Years; Ranolazine; Standard of Care; United States | 2014 |
Impact of angina frequency on health utility values of patients with chronic stable angina.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Female; Health Status Indicators; Humans; Male; Middle Aged; Piperazines; Placebos; Quality of Life; Ranolazine; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States | 2014 |
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
Topics: Acetanilides; Aged; Angina, Stable; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroglycerin; Patient Satisfaction; Piperazines; Quality of Life; Ranolazine; Treatment Outcome; Vasodilator Agents | 2014 |
Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Treatment Outcome | 2014 |
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
Topics: Aged; Angina, Stable; Blood Glucose; Cardiovascular Agents; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Ranolazine; Retrospective Studies | 2015 |
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Topics: Acetanilides; Angina, Stable; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Exercise Test; Exercise Tolerance; Follow-Up Studies; Humans; Incidence; Piperazines; Prospective Studies; Ranolazine; Spain; Treatment Outcome | 2012 |
20 other study(ies) available for ranolazine and Angina, Stable
| Article | Year |
|---|---|
[Diagnostics, therapy and the importance of quality of life in patients with chronic coronary syndrome. Results oft the general practitioner care study ALTHEA].
Topics: Angina, Stable; Coronary Artery Disease; Cross-Sectional Studies; General Practitioners; Humans; Quality of Life; Ranolazine; Syndrome | 2022 |
Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
Topics: Angina Pectoris; Angina, Stable; Cardiovascular Agents; Humans; Ranolazine; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2022 |
COVID-19-related arrhythmias and the possible effects of ranolazine.
Topics: Action Potentials; Angina, Stable; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; COVID-19 Drug Treatment; Cytokines; Hemodynamics; Humans; Inflammation; Potassium Channels; Ranolazine; Sodium Channel Blockers | 2021 |
Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
Topics: Aged; Angina, Stable; Cardiovascular Agents; Coronary Disease; Female; Humans; Male; Microcirculation; Middle Aged; Pilot Projects; Ranolazine; Treatment Outcome | 2017 |
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
Topics: Angina, Stable; Cardiovascular Agents; Cohort Studies; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Humans; Male; Markov Chains; Prospective Studies; Quality of Life; Ranolazine | 2018 |
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Female; Follow-Up Studies; Health Care Costs; Humans; Male; Ranolazine; Retrospective Studies; Time Factors; Treatment Outcome; United States; Veterans | 2018 |
Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Austria; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Ranolazine; Treatment Outcome | 2019 |
Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
Topics: Acetanilides; Angina, Stable; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Humans; Male; Piperazines; Ranolazine; Sodium Channel Blockers | 2013 |
Introduction: Managing patients with chronic angina: emerging therapeutic options for improving clinical efficacy and outcomes.
Topics: Acetanilides; Angina, Stable; Cardiovascular Agents; Chronic Disease; Health Care Costs; Humans; Piperazines; Ranolazine | 2006 |
Advances in the management of stable angina.
Topics: Acetanilides; Angina, Stable; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Humans; Long QT Syndrome; Piperazines; Ranolazine | 2006 |
Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Angina, Stable; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Practice Guidelines as Topic; Quality of Life; Ranolazine; Severity of Illness Index; Sodium Channel Blockers; Surveys and Questionnaires; Treatment Outcome | 2013 |
Use of ranolazine in patients with stable angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Glycated Hemoglobin; Humans; Nitrates; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2014 |
Old and New Drugs for Treatment of Stable Angina.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Drug Discovery; Humans; Nitrates; Ranolazine | 2015 |
Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Comparative Effectiveness Research; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Health Resources; Humans; Male; Nitroglycerin; Ranolazine; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vasodilator Agents | 2015 |
New oral nitric oxide-dependent medications for patients with coronary artery disease who have persistent angina pectoris.
Topics: Administration, Oral; Angina, Stable; Coronary Artery Disease; Humans; Nitric Oxide; Ranolazine; Sodium Channel Blockers; Trimetazidine; Vasodilator Agents | 2015 |
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Topics: Aged; Angina, Stable; Cardiovascular Agents; Chronic Disease; Cost-Benefit Analysis; Drug Costs; Female; Humans; Male; Quality of Life; Quality-Adjusted Life Years; Ranolazine; Sodium Channel Blockers; Surveys and Questionnaires; United Kingdom | 2015 |
Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
Topics: Aged; Aged, 80 and over; Angina, Stable; Cardiovascular Agents; Female; Follow-Up Studies; Greece; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Quality of Life; Ranolazine; Severity of Illness Index; Treatment Outcome | 2016 |
Clinical experience with ranolazine in a veteran population with chronic stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina, Stable; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents; Veterans | 2012 |
Treating stable angina - is there a NICE way towards an international consensus?
Topics: Acetanilides; Angina, Stable; Anti-Arrhythmia Agents; Benzazepines; Cardiac Imaging Techniques; Consensus; Humans; International Cooperation; Ivabradine; Myocardial Revascularization; Nicorandil; Piperazines; Practice Guidelines as Topic; Ranolazine; Vasodilator Agents | 2012 |
Effects of ranolazine on vasomotor responses of rat aortic rings.
Topics: Acetanilides; Angina, Stable; Animals; Aorta; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Piperazines; Ranolazine; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2013 |